Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Placebo Response”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01323374
What this trial is testing

Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With Fibromyalgia

Who this might be right for
Fibromyalgia
Chelsea Therapeutics 122
Large-scale testing (Phase 3)UnknownNCT01579591
What this trial is testing

VSL#3 Versus Placebo in Increasing the Pathological Major Response Rate in Patients With Rectal Cancer

Who this might be right for
Rectal Cancer
Catholic University of the Sacred Heart 160
Large-scale testing (Phase 3)Study completedNCT00240617
What this trial is testing

Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks

Who this might be right for
Migraine Disorders
GlaxoSmithKline 623
Testing effectiveness (Phase 2)Study completedNCT01959282
What this trial is testing

Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 219
Large-scale testing (Phase 3)Ended earlyNCT00418574
What this trial is testing

Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
Menarini Group 888
Large-scale testing (Phase 3)UnknownNCT02561793
What this trial is testing

DHEA Versus Placebo in Women With Poor Ovarian Response

Who this might be right for
Subfertility
Cairo University 440
Large-scale testing (Phase 3)Study completedNCT00783718
What this trial is testing

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Millennium Pharmaceuticals, Inc. 895
Post-approval studies (Phase 4)Study completedNCT00993668
What this trial is testing

Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 224
Early research (Phase 1)Study completedNCT05537038
What this trial is testing

Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers

Who this might be right for
Tuberculosis
BioNTech SE 120
Large-scale testing (Phase 3)UnknownNCT03375814
What this trial is testing

Evaluation Effect of Crocina on The Cellular Immune Responses in Osteoarthritis Patients

Who this might be right for
Osteoarthritis, Knee
Mashhad University of Medical Sciences 40
Testing effectiveness (Phase 2)UnknownNCT01525758
What this trial is testing

Study of SI000413 in Knee Osteoarthritis Patients

Who this might be right for
Osteoarthritis, Knee
Dong-A Pharmaceutical Co., Ltd. 152
Testing effectiveness (Phase 2)Study completedNCT00595413
What this trial is testing

Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)

Who this might be right for
Rheumatoid Arthritis
EMD Serono 311
Testing effectiveness (Phase 2)Ended earlyNCT04026997
What this trial is testing

CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis

Who this might be right for
Gastroparesis
CinDome Pharma, Inc. 72
Large-scale testing (Phase 3)Study completedNCT02720523
What this trial is testing

Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs

Who this might be right for
Rheumatoid Arthritis
AbbVie 197
Testing effectiveness (Phase 2)Looking for participantsNCT06701903
What this trial is testing

Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

Who this might be right for
Generalized Anxiety Disorder
Intra-Cellular Therapies, Inc. 570
Large-scale testing (Phase 3)Looking for participantsNCT06274554
What this trial is testing

Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease

Who this might be right for
Crohn's DiseaseInflammatory Bowel Diseases
Weill Medical College of Cornell University 120
Early research (Phase 1)Study completedNCT07285603
What this trial is testing

A Study in Healthy Subjects to Assess the Safety and Tolerability of a 120-hour Continuous Infusion of M6229

Who this might be right for
Healthy Subjects
Matisse Pharmaceuticals 15
Large-scale testing (Phase 3)Study completedNCT00210769
What this trial is testing

The Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 203
Early research (Phase 1)Study completedNCT00141180
What this trial is testing

CP-481,715 Nickel Allergy Study.

Who this might be right for
Dermatitis, Allergic Contact
Pfizer 48
Large-scale testing (Phase 3)Ended earlyNCT00476996
What this trial is testing

Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 836
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation